Mode
Text Size
Log in / Sign up
N/A Completed N=141 Randomized Other

PORTuguese Research on Telemonitoring With CareLink® (PORTLink)

Source: ClinicalTrials.gov NCT03125382 ↗
Enrolled (actual)
141
Serious AEs
4.5%
Results posted
Feb 2024
Primary outcomePrimary: Number of Patient Satisfied or Very Satisfied With Carelink — 34; 34 Participants

Summary

Compare use of Carelink system - monitoring system - with traditional in-clinic follow up, in patients with implantable cardiac defibrillator (ICD)

Outcome Measures

OutcomeResultp-value
PRIMARY
Number of Patient Satisfied or Very Satisfied With Carelink
34; 34
SECONDARY
Number of Device Related Adverse Events
0; 0; 0; 0
SECONDARY
Physician Satisfaction With Carelink: Total Number of Transmissions With Satisfaction Ratings
98; 80; 25; 47; 0; 0
SECONDARY
Health Care Consumed Resources Between Groups Relative to Unscheduled Visits
1.1; 0.4
SECONDARY
Compare Patient Consumed Resources Between Groups
30; 30; 80; 95
SECONDARY
Compare Patient Consumed Resources Between Groups
30; 30; 80; 95
SECONDARY
Improvement in Quality of Life
0; 0; 0; 0; -1.1; 0.0
SECONDARY
Number of Unanticipated Serious Adverse Device Effects (USADE) Rate
6; 4

Eligibility Criteria

Inclusion Criteria

  • Subject has implanted Medtronic Implantable Cardioverter Defibrillator: CRT-D (Cardiac Resynchronization Therapy - Defibrillator), ICD
  • Subject or the subject's caregiver is willing and able to use the Medtronic CareLink Monitor and perform the required duties at home or have a family member or assistant to perform those studies
  • Subject has signed a Patient Informed Consent Form from this study

Exclusion Criteria

  • Subject has medical condition(s) that would limit study participation (e.g. hearing or speech impaired with no family member or assistant available)
  • Subject is less than 18 years of age
  • Subject is enrolled or intends to participate in another clinical trial
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT03125382). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.

Back to search